Clinical Trial Update: An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients

View source ↗

Summary

An observational study evaluating valganciclovir (Valcyte) for cytomegalovirus infections in D+/R- liver transplant recipients completed, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• Valcyte (valganciclovir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cytomegalovirus Infections | Status: COMPLETED | Results posted: 2016-02-11